New patent expiration for Nalpropion drug CONTRAVE

Contrave, a drug marketed by Nalpropion, is protected by twenty patents with potential for litigation. The drug has 246 patent family members in 44 countries. The generic ingredient in Contrave is bupropion hydrochloride; naltrexone hydrochloride. There is currently one supplier for this compound.